Participating in the "Healthy China 2020 Strategic Research" and "Healthy China 2030 Planning Outline" research and development of the Dai Tao said in an interview with the Science and Technology Daily reporter, the important reason why it is now expensive to see a doctor is that innovative medicines and high-end medical instruments and equipment are mainly dependent on imports, and in the future, we must increase the Bureau of research and development of innovative medicines and instruments and equipment; it is necessary to change In the past, heavy medical care, light preventive health care to the medical-centered service model, shifting to health-centered, to achieve disease prevention and control of the gate forward, the center of gravity sinking, to achieve the "passive medical" to "active health" of the transformation.
Talking about the similarities and differences in the focus of the Healthy China 2020 and 2030 plans, Dai Tao told reporters that after so many years of reform and opening up the accumulation of medical science and technology innovation has been from "running with" "running with" to "running with" the main "Running in parallel" "leading" parallel transformation, "around the needs of the construction of a healthy China, to accelerate the implementation of the national health protection project, to strengthen the prevention and control of major diseases research, precision medicine, translational medicine and other research, transforming the healthcare service style, vigorously promote the transfer and transformation of scientific and technological achievements, and build a number of clinical diagnosis and treatment standards and normative guidelines suitable for China." He emphasized.
"By 2030, the leading and supporting role of medical and health science and technology innovation in safeguarding people's health and promoting the development of health undertakings will be more prominent, the role in the national science and technology innovation system will be more prominent, and the strength of medical and health science and technology innovation will be in the forefront of the world's innovative countries, and will reach the level of the medium developed countries in advance. " Dai Tao said.
Precision medicine, biotherapy, etc. as a key development direction
Academician of the Chinese Academy of Engineering, Peking University, Director of the Department of Medicine, Zhan Qimin, precision medicine is the application of modern genetic technology, molecular imaging technology, bioinformatics technology, combined with the patient's living environment and clinical data to achieve accurate treatment and diagnosis, the development of a personalized program of disease prevention and treatment. Its essence is through the genome, proteome and other genomics technologies and cutting-edge medical technologies, for a large sample of people and specific types of diseases for the analysis and identification of biomarkers, validation and application, so as to accurately find the cause of the disease and the target of the treatment, and a disease of different states and processes of the precise classification, and ultimately to achieve the purpose of personalized and accurate treatment of diseases and specific patients, improve the effectiveness of the diagnosis and treatment and prevention of diseases. The benefits of diagnosis, treatment and prevention can be improved.
He emphasized that the focus of precision medicine is not on "medical" but on "precision". Precision medicine attaches more importance to the depth of the characteristics of the "disease" and the "medicine" of a high degree of accuracy; it is a high level of medical technology based on the in-depth understanding of people, diseases and medicines.
Biological treatments include immunotherapy, gene therapy and so on. In this regard, it is emphasized to seize the strategic opportunity of integration and innovative development of biotechnology and the medical field, to give birth to major original breakthroughs in the field of health care in the cutting-edge technology of biotherapy, to innovate clinical treatment techniques and methods, and to improve the level of clinical rescue and treatment.
Chronic disease opportunities
Chen Zhu, vice chairman of the Standing Committee of the National People's Congress and academician of the Chinese Academy of Sciences, gave a digital description of China's major health indicators to reach the level of the world's developed countries, more than half of the urban and rural areas to meet the standards of the national health city (townships), 50 percent of the national health literacy, chronic premature mortality rate reduced by 1/3, and basically realize health coverage "prevention of illness and medical treatment" and so on. In short, the basic connotation of a healthy China should include a healthy environment, healthy nationals, health coverage of three aspects, is a big health concept.
"Chronic disease prevention and control has become an increasingly important issue in the field of health, because what is left behind now are the oldest problems, and these problems must start from basic research in order to get a breakthrough." Slow disease prevention and control experts, Fudan University's Zhou Xiaoming told Science and Technology Daily reporter. Such as: individual development and differentiation mechanism research, tissue and organ regeneration mechanism research, aging regulation research, brain science and cognitive neuroscience research, health and medical big data mining, new gene manipulation technology.
Chinese medicine innovation
Healthy China 2030, the innovative development of traditional Chinese medicine is also expected. In the process of transforming from the "passive medical" mode to the "active health" mode, based on the traditional Chinese medicine health care and the theory of treating the future disease, it is expected to develop a number of Chinese medicine characteristics of the promotion of health care methods and technologies, as well as a series of function factors are clear, health care function of the exact health care products.